Editors: John Sganga, Joseph Cianfrani and Boris Zelkind
Judgments and Awards
On August 23, 2017, a Massachusetts federal district court entered a second amended final judgement in favor of Brigham and Women’s Hospital, Inc., and Investors Bio-Tech, L.P., against Perrigo Co., finding the asserted patent that protected Pepcid Complete® had been infringed by Perrigo’s sale of a generic product and the patent had not been proven invalid. The final judgement was in accord with a jury verdict of December 14, 2016 where the jury found infringement and awarded damages of over $10 million dollars, the full amount requested. The damages amounted to 3.5 cents per infringing tablet, which was approximately 18% of the sales price of the accused tablets. The jury had also found willful infringement, however, the district court held the plaintiffs were not entitled to attorneys’ fees or enhanced damages.
Subscribe for News and Updates
